Currier R, Puck JM. SCID newborn screening: what we’ve learned. J Allergy Clin Immunol. 2021;147:417–26.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gu X, Wang Z, Ye J, Han L, Qiu W. Newborn screening in China: phenylketonuria, congenital hypothyroidism and expanded screening. Ann Acad Med Singap. 2008;37:107–14.

PubMed  Google Scholar 

Biggs CM, Haddad E, Issekutz TB, Roifman CM, Turvey SE. Newborn screening for severe combined immunodeficiency: a primer for clinicians. CMAJ. 2017;189:E1551–7.

Article  PubMed  PubMed Central  Google Scholar 

Hazenberg MD, Otto SA, de Pauw ES, Roelofs H, Fibbe WE, Hamann D, et al. T-cell receptor excision circle and T-cell dynamics after allogeneic stem cell transplantation are related to clinical events. Blood. 2002;99:3449–53.

Article  CAS  PubMed  Google Scholar 

McDonald-McGinn DM, Sullivan KE, Marino B, Philip N, Swillen A, Vorstman JA, et al. 22q11.2 deletion syndrome. Nat Rev Dis Primers. 2015;1:15071.

Article  PubMed  PubMed Central  Google Scholar 

Dvorak CC, Cowan MJ, Logan BR, Notarangelo LD, Griffith LM, Puck JM, et al. The natural history of children with severe combined immunodeficiency: baseline features of the first fifty patients of the primary immune deficiency treatment consortium prospective study 6901. J Clin Immunol. 2013;33:1156–64.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pai SY, Logan BR, Griffith LM, Buckley RH, Parrott RE, Dvorak CC, et al. Transplantation outcomes for severe combined immunodeficiency, 2000–2009. N Engl J Med. 2014;371:434–46.

Article  CAS  PubMed  PubMed Central  Google Scholar 

van Zelm MC, Szczepanski T, van der Burg M, van Dongen JJ. Replication history of B lymphocytes reveals homeostatic proliferation and extensive antigen-induced B cell expansion. J Exp Med. 2007;204:645–55.

Article  PubMed  PubMed Central  Google Scholar 

Nakagawa N, Imai K, Kanegane H, Sato H, Yamada M, Kondoh K, et al. Quantification of κ-deleting recombination excision circles in Guthrie cards for the identification of early B-cell maturation defects. J Allergy Clin Immunol. 2011;128:223-5.e2.

Article  CAS  PubMed  Google Scholar 

Zetterström RH, Barbaro M, Ohlsson A, Borte S, Jonsson S, Winiarski J, et al. Newborn screening for primary immune deficiencies with a TREC/KREC/ACTB triplex assay—a three-year pilot study in Sweden. Int J Neonat Screen. 2017;3:11.

Article  Google Scholar 

de Felipe B, Olbrich P, Lucenas JM, Delgado-Pecellin C, Pavon-Delgado A, Marquez J, et al. Prospective neonatal screening for severe T- and B-lymphocyte deficiencies in Seville. Pediatr Allergy Immunol. 2016;27:70–7.

Article  PubMed  Google Scholar 

Kimizu T, Nozaki M, Okada Y, Sawada A, Morisaki M, Fujita H, et al. Multiplex real-time PCR-based newborn screening for severe primary immunodeficiency and spinal muscular Atrophy in Osaka, Japan: Our Results after 3 Years. Genes (Basel). 2024;15:314.

Article  CAS  PubMed  Google Scholar 

Pal Singh S, Dammeijer F, Hendriks RW. Role of Bruton’s tyrosine kinase in B cells and malignancies. Mol Cancer. 2018;17:57.

Article  PubMed  PubMed Central  Google Scholar 

King JR, Hammarström L. Newborn screening for primary immunodeficiency diseases: history, current and future practice. J Clin Immunol. 2018;38:56–66.

Article  CAS  PubMed  Google Scholar 

Mercuri E, Sumner CJ, Muntoni F, Darras BT, Finkel RS. Spinal muscular atrophy. Nat Rev Dis Primers. 2022;8:52.

Article  PubMed  Google Scholar 

Keinath MC, Prior DE, Prior TW. Spinal muscular atrophy: mutations, testing, and clinical relevance. Appl Clin Genet. 2021;14:11–25.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lefebvre S, Bürglen L, Reboullet S, Clermont O, Burlet P, Viollet L, et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell. 1995;80:155–65.

Article  CAS  PubMed  Google Scholar 

Strauss KA, Farrar MA, Muntoni F, Saito K, Mendell JR, Servais L, et al. Onasemnogene abeparvovec for presymptomatic infants with three copies of SMN2 at risk for spinal muscular atrophy: the Phase III SPR1NT trial. Nat Med. 2022;28:1390–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Corey DR. Nusinersen, an antisense oligonucleotide drug for spinal muscular atrophy. Nat Neurosci. 2017;20:497–9.

Article  CAS  PubMed  Google Scholar 

Paik J. Risdiplam: a review in spinal muscular atrophy. CNS Drugs. 2022;36:401–10.

Article  CAS  PubMed  Google Scholar 

Health Resources & Services Administration (HRSA). Recommended uniform screening panel. In: Advisory Committee on Heritable Disorders in Newborns and Children. 2024. https://www.hrsa.gov/advisory-committees/ heritable-disorders/rusp. Accessed 10 Jan 2024.

Simard LR, Bélanger MC, Morissette S, Wride M, Prior TW, Swoboda KJ. Preclinical validation of a multiplex real-time assay to quantify SMN mRNA in patients with SMA. Neurology. 2007;68:451–6.

Article  CAS  PubMed  Google Scholar 

Taylor JL, Lee FK, Yazdanpanah GK, Staropoli JF, Liu M, Carulli JP, et al. Newborn blood spot screening test using multiplexed real-time PCR to simultaneously screen for spinal muscular atrophy and severe combined immunodeficiency. Clin Chem. 2015;61:412–9.

Article  CAS  PubMed  Google Scholar 

Gutierrez-Mateo C, Timonen A, Vaahtera K, Jaakkola M, Hougaard DM, Bybjerg-Grauholm J, et al. Development of a multiplex real-time PCR assay for the newborn screening of SCID, SMA, and XLA. Int J Neonat Screen. 2019;5:39.

Article  Google Scholar 

McCandless SE, Wright EJ. Mandatory newborn screening in the United States: history, current status, and existential challenges. Birth Defects Res. 2020;112:350–66.

Article  CAS  PubMed  Google Scholar 

Rechavi E, Lev A, Simon AJ, Stauber T, Daas S, Saraf-Levy T, et al. First year of Israeli newborn screening for severe combined immunodeficiency-clinical achievements and insights. Front Immunol. 2017;8:1448.

Article  PubMed  PubMed Central  Google Scholar 

Verbsky JW, Baker MW, Grossman WJ, Hintermeyer M, Dasu T, Bonacci B, et al. Newborn screening for severe combined immunodeficiency; the Wisconsin experience (2008–2011). J Clin Immunol. 2012;32:82–8.

Article  PubMed  Google Scholar 

Chien Y-H, Yu H-H, Lee N-C, Ho H-C, Kao S-M, Lu M-Y, et al. Newborn screening for severe combined immunodeficiency in Taiwan. Int J Neonat Screen. 2017;3:16.

Article  Google Scholar 

Ryser O, Morell A, Hitzig WH. Primary immunodeficiencies in Switzerland: first report of the national registry in adults and children. J Clin Immunol. 1988;8:479–85.

Article  CAS  PubMed  Google Scholar 

Matamoros Florí N, Mila Llambi J, Español Boren T, Raga Borja S, Fontan CG. Primary immunodeficiency syndrome in Spain: first report of the National Registry in Children and Adults. J Clin Immunol. 1997;17:333–9.

Article  PubMed  Google Scholar 

Stray-Pedersen A, Abrahamsen TG, Frøland SS. Primary immunodeficiency diseases in Norway. J Clin Immunol. 2000;20:477–85.

Article  CAS  PubMed  Google Scholar 

Broides A, Nahum A, Mandola AB, Rozner L, Pinsk V, Ling G, et al. Incidence of typically severe primary immunodeficiency diseases in consanguineous and non-consanguineous populations. J Clin Immunol. 2017;37:295–300.

Article  PubMed  Google Scholar 

Winkelstein JA, Marino MC, Lederman HM, Jones SM, Sullivan K, Burks AW, et al. X-linked agammaglobulinemia: report on a United States registry of 201 patients. Medicine (Baltimore). 2006;85:193–202.

Article